Journal
EUROPEAN JOURNAL OF RADIOLOGY
Volume 73, Issue 3, Pages 481-493Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.ejrad.2009.12.024
Keywords
Endocrine tumours; Diagnostic strategies; PET and PET/CT; Radiopharmaceuticals
Ask authors/readers for more resources
Functional information provided by PET tracers together with the superior image quality and the better data quantification by PET technology had a changing effect on the significance of nuclear medicine in medical issues. Recently introduced hybrid PET/CT systems together with the introduction of novel PET radiopharmaceuticals have contributed to the fact that nuclear medicine has become a growing diagnostic impact on endocrinology. In this review imaging strategies, different radiopharmaceuticals including the basic mechanism of their cell uptake, and the diagnostic value of PET and PET/CT in endocrine tumours except differentiated thyroid carcinomas will be discussed. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available